Understanding How does HAEGARDA work to Prevent HAE Attacks?
•
3 min read
Hereditary Angioedema (HAE) is a rare genetic condition, affecting an estimated 1 in 10,000 to 1 in 50,000 people, which causes unpredictable and debilitating swelling attacks. To combat this, HAEGARDA is a subcutaneous injectable medication that works to prevent these painful episodes by addressing the underlying protein deficiency.
